Recent insider selling at AptarGroup could be seen as a negative sign, implying a lower price is reasonable. Despite profitability and growing profits, the level of insider ownership isn't particularly high, warranting caution.
AptarGroup's consistent growth and significant insider ownership are seen as positive indicators for the company's future performance. The company's ability to generate consistent profits is expected to continue adding long-term value for shareholders.
Given the steady ROCE and level of capital employed, AptarGroup may not be a multi-bagger going forward. The stock has returned a total of 38% to shareholders over the last five years, suggesting that investors may have better chances elsewhere.
Despite market headwinds, investors expect AptarGroup to flourish, inflating its P/E ratio. However, with its growth projection matching the market, the rationale behind its high P/E ratio is being questioned. There are risks of share price drop if the P/E ratio doesn't align with growth prediction.
Aptar is a US packaging company that is global leader in drug delivery, consumer product dispensing, and active material science solutions. It achieved revenue and profit growth over the past 11 years, but its ROE in 2022 was what it was in 2012. This was because its operating efficiencies have been declining. You may think that this is a bad performance until you look at SGX’sNew Toyo(the holding company for Bursa’s Tien Wah Press). The ROE of bot...
Bank of America analysts express optimism for the packaging sector, seeing Crown Holdings, Sealed Air, WestRock, and AptarGroup as promising investment opportunities.
AptarGroup股票討論區
Aptar – standstill ROE over the past 11 years
You may think that this is a bad performance until you look at SGX’s New Toyo (the holding company for Bursa’s Tien Wah Press). The ROE of bot...
MONEY MONDAY WATCH 🔥⚡️🚀 + UPCOMING EARNINGS
$美國鋁業公司(AA.US)$$AptarGroup(ATR.US)$$Aurora Acquisition Corp(AURC.US)$$BioNexus Gene Lab(BGLC.US)$$Bluejay Diagnostics(BJDX.US)$$博伊德賭場(BYD.US)$$中國天然資源(CHNR.US)$$Enphase Energy(ENPH.US)$$第一太陽能(FSLR.US)$$美高梅(MGM.US)$$OKYO Pharma(OKYO.US)$$佩恩國民博彩(PENN.US)$$Sleep Number(SNBR.US)$$普信集團(TROW.US)$$永利度假村(WYNN.US)$$埃克西爾能源(XEL.US)$
2023Q1營收增長1.8%,營業利潤下滑2.6%,淨利潤下滑12.5%。
目前市盈率32.4,市盈率TTM略增到32.4,和增長率相比缺乏吸引力。
專欄US Top Gap Ups and Downs on 2/7: OSH, BIDU, PSO, CHWY and More
Gap Ups
1.$Oak Street Health(OSH.US)$ -up 26.6%
2.$百度(BIDU.US)$ -up 7.5%
3.$英國石油(BP.US)$ -up 3.2%
4.$Fiserv(FISV.US)$ -up 2.4%
5.$三菱日聯金融(MUFG.US)$ -up 1.4%
6.$葛蘭素史克(GSK.US)$ -up 0.8%
7.$微軟(MSFT.US)$ -up 0.7%
8.$賽諾菲安萬特(SNY.US)$ -up 0.5%
9.$Activision Blizzard(ATVI.US)$ -up 0.4%...
暫無評論